Ratings Lincoln National Corporation

Equities

LNC

US5341871094

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
32.99 ^USD	+1.29%		+1.01%	+22.32%

May. 24	Declaration of voting result by Lincoln National Corporation	CI
May. 23	Lincoln National Keeps Quarterly Dividend at $0.45 a Share, Payable Aug. 1 to Shareholders of Record July 10	MT

Strengths

Its low valuation, with P/E ratio at 6.07 and 4.72 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
With regards to fundamentals, the enterprise value to sales ratio is at 0.69 for the current period. Therefore, the company is undervalued.
The company's share price in relation to its net book value makes it look relatively cheap.
The company has a low valuation given the cash flows generated by its activity.
The company is one of the best yield companies with high dividend expectations.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.

Weaknesses

For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
LINCOLN NATIONAL CORPORATION	+22.32%	5.61B	B+
AXA	+12.07%	78.88B	B-
METLIFE, INC.	+9.44%	51.46B	B+
AFLAC INCORPORATED	+8.93%	51.07B	B
MANULIFE FINANCIAL CORPORATION	+20.90%	46.59B	B+
PRUDENTIAL FINANCIAL, INC.	+16.04%	43.21B	B+
GENERALI	+23.53%	39.69B	B
SUN LIFE FINANCIAL INC.	-0.60%	29.1B	B
GREAT-WEST LIFECO INC.	-6.79%	27.94B	B-
PRUDENTIAL PLC	-15.80%	26.05B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes